Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy.
Sato Y, Casson CN, Matsuda A, Kim JI, Shi JQ, Iwasaki S, Chen S, Modrell B, Chan C, Tavares D, Austen D, Ida K, Tayber O, Hein P, Comeau R, Lin Y, Shaw MH.
Sato Y, et al.
Cancer Immunol Immunother. 2022 Oct;71(10):2421-2431. doi: 10.1007/s00262-022-03170-z. Epub 2022 Mar 3.
Cancer Immunol Immunother. 2022.
PMID: 35237846
Free PMC article.